News > China approves single-dose Covid vaccine to rival J&J's shot: Report
China approves single-dose Covid vaccine to rival J&J's shot: Report
Business Standard | 28/02/2021 08:49 PM | Click to read full article
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator on Sunday.
China's first Ad5-nCoV COVID-19 vaccine was rolled out on Friday. Phase-I clinical trials of the vaccine started on March 16, last year, making it the world's first COVID-19 candidate vaccine that entered clinical trials, it said. It is the only single-dose COVID-19 vaccine that has been given conditional approval to be rolled out in China.